Massimo Morfini
- Hematology top 0.05%
- Hemophilia Treatment and Research 169
- Platelet Disorders and Treatments 82
- Blood Coagulation and Thrombosis Mechanisms 56
- Chronic Myeloid Leukemia Treatments 30
- Hemostasis and retained surgical items 18
- Blood groups and transfusion 13
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 31
- Internal Medicine top 5%
- Hepatology top 5%
- Biochemistry top 10%
-
- Cancer-related gene regulation 14
- Co-authors
- Elena SantagostinoAngiola RocinoPier Mannuccio MannucciAndrea MessoriGiovanni LongoClaude NégrierA. GringeriRolf Ljung
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Massimo Morfini
193 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 108
- Hematology 5.4k
- Genetics 1.3k
- Internal Medicine 123
- Hepatology 216
- Biochemistry 76
Countries citing papers authored by Massimo Morfini
This map shows the geographic impact of Massimo Morfini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Morfini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Morfini more than expected).
Fields of papers citing papers by Massimo Morfini
This network shows the impact of papers produced by Massimo Morfini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Morfini. The network helps show where Massimo Morfini may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Massimo Morfini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2019 | 11 | |
| 3 | 2019 | 11 | |
| 4 | 2018 | 1 | |
| 5 | 2018 | 44 | |
| 6 | 2017 | 1 | |
| 7 | 2017 | 37 | |
| 8 | 2015 | 10 | |
| 9 | 2011 | 1 | |
| 10 | 2011 | 28 | |
| 11 | 2010 | 7 | |
| 12 | 2007 | 39 | |
| 13 | La viscosupplementazione nel trattamento dell’artropatia emofilica | 2006 | 0 |
| 14 | 2006 | 19 | |
| 15 | 2006 | 35 | |
| 16 | 2004 | 33 | |
| 17 | 1997 | 47 | |
| 18 | Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite. | 1994 | 10 |
| 19 | 1989 | 22 | |
| 20 | 1987 | 50 |
About Massimo Morfini
Massimo Morfini is a scholar working on Hematology, Genetics, Hepatology, Management of Technology and Innovation and Internal Medicine, having authored 199 papers that have together received 6.1k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (169 papers), Platelet Disorders and Treatments (82 papers), Blood Coagulation and Thrombosis Mechanisms (56 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (31 papers), Chronic Myeloid Leukemia Treatments (30 papers), Hemostasis and retained surgical items (18 papers), Cancer-related gene regulation (14 papers) and Blood groups and transfusion (13 papers). The work is most often cited by research in Hematology (5.4k citations), Genetics (1.3k citations), Internal Medicine (123 citations), Hepatology (216 citations) and Biochemistry (76 citations). Massimo Morfini has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Elena Santagostino, Angiola Rocino, Pier Mannuccio Mannucci, Andrea Messori, Giovanni Longo, Claude Négrier, A. Gringeri, Rolf Ljung, Silvia Linari and Alfonso Iorio. Their work appears in journals such as Haemophilia, Thrombosis and Haemostasis, Blood, Journal of Thrombosis and Haemostasis and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.